GeoVax News Releases

Global Infectious Disease Preparedness and Need for Increased Vaccine Funding

Turn on the TV or flip through social media and the coronavirus outbreak in Wuhan, China dominates the headlines. The situation is continually evolving, with seemingly exponential increases in the numbers each day with rapid expansion of infected populations beyond China. The ...

View full release

GeoVax Reports 2019 Third Quarter Financial Results and Provides Corporate Update

ATLANTA, GA, November 7, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human immunotherapies and vaccines, today announced its financial results for the quarter ended September 30, 2019 and provided an update on its corporate development progress. ...

View full release

Leveraging GeoVax's Vaccine Expertise To Take On Cancer

GeoVax Labs, Inc. (OTCQB:GOVX), a biotechnology company developing human immunotherapies and vaccines has historically been associated with the development of vaccines against infectious diseases. The company  is now leveraging the knowledge and expertise it has validated in i...

View full release